Dividends

DGXQuest Diagnostics

StockNYSEUnited StatesHealth careEU retail investors: available

+1.6% today · +47.1% over a year

10/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 95% of the instruments we score

Stability, Dividend safety: among the best of its peers; priced lower than most peers. Dividend yield 1.30%.

Quest Diagnostics (DGX) dividends: trailing yield 1.30%, Dividend Safety 83/100, not lowered for 22 years, 5-year growth 6.9% a year.

Trailing 12-month yieldA high yield can signal risk rather than safety: payouts may be cut, and part of a fund's distribution may be your own capital returned.
1.30%
Forward yield (next or typical regular payment, annualised)
1.32%
Dividends per share, last 12 months
$3.38
Payments per year
4
Dividend safety0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks.
83 / 100
Very safe

Yield after tax (estimate)

Before tax → After tax, CY non-dom

Last 12 months
1.30% → 1.07%
Forward
1.32% → 1.09%

Of every 100 paid out

Withheld at source (United States)
15.00%
Cyprus Special Defence Contribution (after credit for foreign tax)
0.00%
Cyprus GeSY health contribution
2.65%
You keep
82.35%
  • Source country assumed: United States (from the issuer’s data). Depositary receipts and companies listed outside their home country may be taxed by that home country.
  • US rate 15 % assumes a W-8BEN form is on file with your broker (US–Cyprus treaty); without it the US withholds 30 %.
  • GeSY 2.65 % applies to dividends and interest of every Cyprus resident, domiciled or not, up to €180,000 of income a year.

Cyprus resident, domiciled: 1.07%

Estimate, not tax advice: published rules as of 2026-10-14 for the profile chosen; your broker’s withholding and your own situation can differ. How we estimate tax

Next payment

No upcoming payment has been announced yet.

Dividend profile

5-year dividend growth (per year)
+6.9%
Years without a lower dividend
22
Years without a cut of over 10 %
22
Payout ratio (earnings)
34%
Payout ratio (free cash flow)
27%

Annual total matches the company's SEC filing

Dividends per share by year

Sum of payments by calendar year of the ex-date; the current year is left out until it ends.

Dividends per share by year: 2017 $1.80, 2018 $1.95, 2019 $2.12, 2020 $2.21, 2021 $2.42, 2022 $2.60, 2023 $2.79, 2024 $2.96, 2025 $3.152017: $1.802018: $1.952019: $2.122020: $2.212021: $2.422022: $2.602023: $2.792024: $2.962025: $3.15

Payment history

Amounts are per share on today's share count (adjusted for splits), before withholding tax.

Status
06 Oct 202622 Oct 2026$0.86RegularVerified2
08 Jul 202623 Jul 2026$0.86RegularVerified2
06 Apr 202622 Apr 2026$0.86RegularVerified2
13 Jan 202629 Jan 2026$0.80RegularVerified2

Each payment is checked against up to 2 data feeds. Several feeds can share one upstream, so Verified needs two independent ones. Verified: two or more sources agree. Single source: not cross-checked yet. Sources disagree: the median is shown. Announced: declared, may still change.

What dividend safety is made of

0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks.

Similar dividend payers

Same sector and region, closest in dividend yield.

RPRXRoyalty Pharma plc1.3%386
NHCNational HealthCare Corporation1.2%8522
PAHCPhibro Animal Health Corporation1.4%6212
LMATLeMaitre Vascular Inc.1.2%8015
SYKStryker1.1%8524
RMDResMed Inc1.0%8714
ELVElevance Health1.6%8815
XRAYDentsply Sirona1.7%0—

A high yield is not a high return: payouts can come from your own capital and can be cut. Dividend calculator →